SHINE Medical Technologies

SHINE Medical Technologies is committed to becoming a global leader in the production of medical isotopes. The company initially focused its fusion-based technology on advanced industrial imaging and the production of diagnostic and therapeutic isotopes. These isotopes include Molybdenum-99 (a diagnostic isotope used for diagnosing heart disease, cancer, and other conditions) and Lutetium-177 (a therapeutic isotope that holds promise for significantly improving outcomes for certain cancer patients). In addition to advanced industrial imaging and medical isotopes, SHINE has developed a long-term strategy to address some of humanity’s greatest challenges, including nuclear waste recycling and the production of clean fusion energy, by pursuing our vision of progressively broader and more impactful applications of fusion technology.